E Fund Management Co. Ltd. Acquires Shares of 45,010 Coherus BioSciences, Inc. (NASDAQ:CHRS)

E Fund Management Co. Ltd. purchased a new stake in Coherus BioSciences, Inc. (NASDAQ:CHRS – Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund purchased 45,010 shares of the biotechnology company’s stock, valued at approximately $168,000. Several other institutional investors also recently bought and sold shares of […]

Related Keywords

United States ,Dennism Lanfear ,Robertw Baird ,Coherus Biosciences ,Vanguard Group Inc ,Barclays Plc ,Barclays ,E Fund Management Co ,Maxim Group ,Coherus Biosciences Inc ,Blackrock Inc ,Nasdaq ,Coherus Biosciences Company Profile ,Free Report ,Street Corp ,Coherus Biosciences Daily ,Nasdaq Chrs ,Chrs ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,